NCT02526615 - Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2001

Conditions

Insulin SensitivityType 2 Diabetes

Interventions

DRUG

Rosiglitazone

Patients received either placebo, metformin or rosiglitazone

DRUG

Metformin

Patients received either placebo, metformin or rosiglitazone

DRUG

Placebo

Patients received either placebo, metformin or rosiglitazone

Trial Locations (3)

Turku PET Centre, Turku

Turku university hospital, PET center, Turku

Turku PET Centre (Turku University Hospital), Turku